Does tumour uptake of Foscan determine PDT efficacy?

International Journal of Cancer

Volumn 73, Issue 2, 1997, Pages 236-239

  Veenuizen, Ruth ^a   Oppelaar, Hugo ^a   Ruevekamp, Marjan ^a   Schellens, Jan ^a   Dalesio, Otilia ^a   Stewart, Fiona ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOSENSITIZING AGENT; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TISSUE LEVEL; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; CARBON RADIOISOTOPES; FEMALE; FIBROSARCOMA; INJECTIONS, INTRAVENOUS; MESOPORPHYRINS; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TUMOR CELLS, CULTURED;

EID: 0030769884     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971009)73:2<236::AID-IJC13>3.0.CO;2-D     Document Type: Article

References (19)

1. ALIAN, W., ANDERSSON-ENGELS, S., SVANBERG, K. and SVANBERG, S., Laser-induced fluorescence studies of meso-tetra(hydroxyphenyl)chlorin in malignant and normal tissues in rats. Brit. J. Cancer, 70, 880-885 (1994).
2. ANSELL, J.K., DE JODE, M.L., GRAHN, M.F., MAUDSLEY, J. and WILLIAMS, N.S., Correlation of photodynamic effect with surface fluorescence and drug assay. Lasers surg. Med., suppl. 7, 41-12 (1995).
3. BERENBAUM, M.C., HALL, G.W. and HOYES, A.D., Cerebral photosensitisation hy haematoporphyrin derivative. Evidence for an endothelial site of action. Brit. J, Cancer, 53, 81-89 (1986).
4. BOWN, S.G., TRALAU, C.J., COLERIDGE SMITH, P.D., AKDEMIR, D. and WIEMAN, T.J., Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Brit. J. Cancer, 54, 43-52 (1986).
5. BUGELSKI, P.J., PORTER, C.W. and DOUGHERTY, T.J., Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res., 41, 4606-4612 (1981).
6. DOUGHERTY, T.J., Yearly Review. Photodynamic therapy. Photochem. Photobiol., 58, 895-900 (1993).
7. GOMER, C.J. and FERRARIO, A., Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 50, 3985-3990 (1990).
8. HENDERSON, B.W. and DOUGHERTY, T.J., Review article. How does photodynamic therapy work? Photochem. Photobiol., 55, 145-157 (1992).
9. HENDERSON, B.W., WALDOW, S.M., MANG, T.S., POTTER, W.R., MALONE, P.B. and DOUGHERTY, T.J., Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res., 45, 572-576 (1985).
10. MA, L.W., MOAN, J. and BERG, K., Comparison of the photobleaching effect of three photosensitizing agents: meso-tetra(m-hydroxyphenyl)chlorin, meso-tetra(m-hydroxy-phenyl)porphyrin and photofrin during photodynamic therapy. Lasers med. Sci., 9, 127-132 (1994).
11. MORLET, L., VONARX-COINSMANN, V., LENZ, P., FOULTIER, M., DE BRITO, L.X., STEWART, C.M. and PATRICE, T., Correlation between meta(tetrahydroxyphenyl)chlorin (m-THPC) biodistribution and photodynamic effects in mice. Photochem. Photobiol., 28, 25-32 (1995).
12. REED, M.W., WIEMAN, T.J., SCHUSKE, D.A., TSENG, M.T. and MILLER, F.N., A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. Radiat. Res., 119, 542-552 (1989).
13. RIS, H.B., AlTERMATT, H.J., INDERBITZI, R., HESS, R. NACHBUR, B., STEWART, J.C.M., WANG. Q., LIM, C.K., BONNETT, R., BERENBAUM, M.C. and ALTHAUS, U., Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Brit. J. Cancer, 64, 1116-1120 (1991).
14. Ris, H.B., ALTERMATT, H.J., NACHBUR, B., STEWART, J.C.M., WANG, Q., LIM, C.K., BONNETT, R. and ALTHAUS, U. Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma. Int. J. Cancer, 53, 141-146 (1993).
15. SELMAN, S.H., KREIMER-BIRNBAUM, M., KLAUNIG, J.E., GOLDBLATT, P.J., KECK, R.W. and BRITTON, S.L., Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res., 44, 1924-1927 (1984).
16. STAR, W.M., MARIJNISSEN, H.P.A., VAN DEN BERG-BLOK, A.E., VERSTEEG, J.A., FRANKEN, K.A.P. and REINHOLD, H.S., Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin-derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res., 46, 2532-2540 (1986).
17. TROMBERG, B.J., ORENSTEIN, A., KIMEL, S., BARKER, S.J., HYATT, J., NELSON, J.S. and BERNS, M.W., In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photocherm. Photobiol., 52, 375-385 (1990).
18. UNÖLD, E., ELL, C., JOCHAM, D., SROKA, R. and STOCKER, S., Quantitative and comparative study of haematoporphyrin-derived photosensitizes on a murine tumour model. Lasers med. Sci, 5, 309-316 (1990).
19. VAN GEMERT, J.C., BERENBAUM, M.C. and GIJSBERS, G.H.M., Wavelengthand light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Brit. J. Cancer, 52, 43-49 (1985).